The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration
Basnak'ian, I.A.; Alliluev, A.P.; Kuvakina, V.I.; Aleksakhina, N.N.; Kotel'nikova, O.V.; Chulok, T.A.; Karabak, V.i.; Borovkova, V.M.; Valerius, I.I.; Gofman, I.L.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 66-67
1994
ISSN/ISBN: 0372-9311 PMID: 7879546 Document Number: 428731
Document emailed within 1 workday
Related Documents
Kuvakina, V.I.; Golovina, L.I.; Mishina, A.I.; Skirda, T.A.; Bobyleva, G.V.; Mikheeva, N.G.; Chernyshova, T.F.; Temper, R.M.; Ermolenko, Z.N. 2002: Evaluation of the immunological activity and safety of group B meningococcal vaccine prepared from a natural complex of specific polysaccharide and outer membrane proteins Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 33-37Beuvery, E.C.; Speijers, G.J.; Lutz, B.I.; Freudenthal, D.; Kanhai, V.; Haagmans, B.; Derks, H.J. 1986: Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use Developments in Biological Standardization 63: 117-128
Pereiró, I.; Díez-Domingo, J.; Morant, A.; Gimeno, C.; Lerma, M.; San-Martín, M.; González, A. 2001: Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine Scandinavian Journal of Infectious Diseases 33(8): 581-584
Sanborn, W.R.; Bencić, Z.; Cvjetanović, B.; Gotschlich, E.C.; Pollock, T.M.; Sippel, J.E. 1971: Trial of a serogroup a meningococcus polysaccharide vaccine in Nigeria Progress in Immunobiological Standardization 5: 497-505
Bogacheva, N.V.; Darmov, I.V.; Borisevich, I.V.; Kriuchkov, A.V.; Pechenkin, D.V. 2009: The time course of changes in cell immunological parameters during administration of live dry plague vaccine Klinicheskaia Laboratornaia Diagnostika 8: 24-27
Dong, B.-q.; Ye, Q.; Cui, X.-l.; Yang, J.; Gong, J.; Yang, M.; Liao, H.-z.; Wei, S.-l.; Zhang, J.; Wu, X.-h.; Si, G.-a.; Yang, H.-h.; Tsuzuki, A.; Park, J.; Ali, M.; Ochiai, L.R.; Clemens, J.D. 2007: Evaluation on the safety of a group a + C meningococcal polysaccharide vaccine Zhonghua Liu Xing Bing Xue Za Zhi 28(5): 417-421
Arushanian, E.B.; Botvev Orkhiĭ, P. 1991: The dissimilar effects of the single and prolonged administration of melatonin on the hypnogenic action of hexenal in mice in relation to the dose and the time of day Farmakologiia i Toksikologiia 54(5): 7-10
Saliou, P.; Stoeckel, P.; Lafaye, A.; Rey, J.L.; Renaudet, J. 1978: Controlled tests of anti-meningococcal polysaccharide a vaccine in the African Sahel area (Upper Volta and Mali) Developments in Biological Standardization 41: 97-108
Kerdpanich, A.; Hutagalung, Y.; Watanaveeradej, V.; Bock, H.L.; Steinhoffmd, M. 2007: The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine Journal of the Medical Association of Thailand 90(7): 1330-1336
Olson, J.W.; Russell, D.H. 1979: Prolonged induction of hepatic ornithine decarboxylase and its relation to cyclic adenosine 3':5'-monophosphate-dependent protein kinase activation after a single administration of diethylnitrosamine Cancer Research 39(8): 3074-3079
Meyer, M.; Gahr, M. 1993: Immunological principles of polysaccharide-protein conjugate vaccination Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 141(10): 770
Zhang, H.M.; Li, Y.P.; Song, L.H.; Yu, X.L.; Liu, N.H.; Kong, X.E.; Li, L.; Zhai, Y.L. 1987: Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine Chinese Medical Journal 100(5): 425-428
Ambrosino, D.M.; Bolon, D.; Collard, H.; Van Etten, R.; Kanchana, M.V.; Finberg, R.W. 1992: Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages Journal of Immunology 149(12): 3978-3983
Del'vig, A.A.; Semenov, B.F. 1999: The capsular polysaccharide of serogroup-B meningococci: its immunobiological properties Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 52-56
Yeh, S.J.; Huang, L.M.; Chen, J.M.; Lee, P.I.; Chang, L.Y.; Lin, Y.J.; Chiu, H.H.; Lee, C.Y. 1997: Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine Journal of the Formosan Medical Association 96(2): 110-115
Lenoir, A.A.; Granoff, P.D.; Granoff, D.M. 1987: Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants Pediatrics 80(2): 283-287
Etienne, J.; Sperber, G.; Adamou, A.; Picq, J.J. 1990: Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger) Medecine Tropicale: Revue du Corps de Sante Colonial 50(2): 227-229
Nicolas, P. 2001: Serogroup W135 meningococcal meningitis epidemic in 2000 and 2001 Medecine Tropicale: Revue du Corps de Sante Colonial 61(3): 259-261
Howard, J.G.; Christie, G.H.; Jacob, M.J.; Elson, J. 1970: Studies on immunological paralysis. 3. Recirculation and antibody-neutralizing activity of 14C-labelled type 3 pneumococcal polysaccharide in paralysed mice Clinical and Experimental Immunology 7(4): 583-596
Soult Rubio, J.A.; Muñoz Sáez, M.; López Castilla, J.D.; Rodríguez Becerra, A.; Romero Parreño, A.; Tovaruela Santos, A. 2000: Continuing increase in the incidence of serogroup C meningococcal disease. Should we decide to vaccinate? Anales Espanoles de Pediatria 53(1): 75-76